| Typicality: | 0.369 |
| Saliency: | 0.278 |
| in up to 10 patients | 4 | other |
| trial → evaluate → preliminary efficacy | 9 |
| trial → be designed to assess → preliminary efficacy | 8 |
| negative | neutral | positive |
| 0.034 | 0.819 | 0.146 |
| Raw frequency | 17 |
| Normalized frequency | 0.278 |
| Modifier score | 0.500 |
| Perplexity | 138.688 |